Daniel J. Gerritzen Sells 5,310 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS) Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) General Counsel Daniel J. Gerritzen sold 5,310 shares of the stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total transaction of $132,006.60. Following the completion of the transaction, the general counsel now owns 110,767 shares of the company’s stock, valued at $2,753,667.62. This represents a 4.57 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

OrthoPediatrics Stock Performance

NASDAQ:KIDS opened at $25.54 on Friday. The company has a current ratio of 7.17, a quick ratio of 3.68 and a debt-to-equity ratio of 0.19. The firm has a 50-day moving average price of $24.84 and a two-hundred day moving average price of $25.53. OrthoPediatrics Corp. has a twelve month low of $21.02 and a twelve month high of $35.99. The company has a market capitalization of $620.29 million, a P/E ratio of -20.76 and a beta of 1.22.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings results on Tuesday, March 4th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.04. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. The company had revenue of $52.67 million for the quarter, compared to analysts’ expectations of $51.16 million. During the same period last year, the company earned ($0.23) EPS. As a group, research analysts expect that OrthoPediatrics Corp. will post -0.93 earnings per share for the current fiscal year.

Institutional Investors Weigh In On OrthoPediatrics

Several hedge funds have recently modified their holdings of KIDS. Millennium Management LLC acquired a new stake in shares of OrthoPediatrics during the 4th quarter worth about $9,798,000. Point72 Asset Management L.P. acquired a new stake in shares of OrthoPediatrics during the 4th quarter worth about $7,450,000. Wasatch Advisors LP boosted its stake in shares of OrthoPediatrics by 47.2% during the 4th quarter. Wasatch Advisors LP now owns 696,318 shares of the company’s stock worth $16,141,000 after purchasing an additional 223,217 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of OrthoPediatrics by 20.2% during the 4th quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company’s stock worth $24,601,000 after purchasing an additional 178,078 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in shares of OrthoPediatrics by 29.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 671,968 shares of the company’s stock worth $15,576,000 after purchasing an additional 152,681 shares during the last quarter. 69.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

KIDS has been the subject of a number of research analyst reports. Truist Financial cut their price target on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. Stifel Nicolaus dropped their target price on shares of OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating for the company in a report on Wednesday, March 5th. Finally, Needham & Company LLC restated a “buy” rating and set a $42.00 target price on shares of OrthoPediatrics in a report on Wednesday, March 5th.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.